Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nastech begins phase I trial of intranasal interferon alfa

Jan. 31, 2001

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Jan. 31, 2001

Kosan receives NCI grant to improve epothilone production

Jan. 31, 2001

Merck reports synthesis, use of new peptidomimetic protein prenyltransferase inhibitors

Jan. 30, 2001

Inhibitors of JNK, compositions and methods of use described by Vertex team

Jan. 30, 2001

New heterocyclic chemopreventive agents described in U.S. patent

Jan. 30, 2001

Cel-Sci/NCI CRADA renewed and expanded

Jan. 30, 2001

Enrollment begins in phase III trial of Leuprogel 4-month for prostate cancer

Jan. 30, 2001

Production, development of recombinant mammastatin planned by Biotherapies

Jan. 30, 2001

Oxford BioMedica and AHP jointly develop novel antibody cancer therapy

Jan. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...